Global active pharmaceutical ingredients (API) market will reach $293.5 billion by 2026, growing by 7.2% annually over 2020-2026 owing to the rising need for medicine and pharmaceutical agents amid the COVID-19 pandemic.
Highlighted with 91 tables and 99 figures, this 190-page report “Global Active Pharmaceutical Ingredients (API) Market 2020-2026 by Synthesis (Synthetic, Biotech, HPAPI), Manufacturing Process (Captive, Merchant), Therapeutic Application, Drug Type, and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global API market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2026 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global API market in every aspect of the classification from perspectives of Synthesis, Manufacturing Process, Therapeutic Application, Drug Type, and Region.
Based on Synthesis, the global market is segmented into the following sub-markets with annual revenue for 2015-2026 included in each section.
Synthetic API
• Branded Synthetic API
• Generic Synthetic API
Biotech API by Drug Type:
• Monoclonal Antibodies
• Recombinant Proteins
• Vaccines
• Other Biotech APIs
Biotech API by Customer Base:
• Innovative Biologic API
• Generic Biosimilar API
Biotech API by Expression Technology:
• Mammalian Expression
• Microbial Expression
• Yeast Expression
• Insect Expression
• Other Expression Technologies
HPAPI
• Branded HPAPI
• Generic HPAPI
Based on Manufacturing Process, the global market is segmented into the following sub-markets with annual revenue for 2015-2026 included in each section.
Captive Manufacturing
• Branded Captive API
• Generic Captive API
Merchant Manufacturing by Drug Type:
• Branded Merchant API
• Generic Merchant API
Merchant Manufacturing by Drug Synthesis:
• Merchant Synthetic API
• Merchant Biotech API
Based on Therapeutic Application, the global market is segmented into the following sub-markets with annual revenue for 2015-2026 included in each section.
• Infectious Diseases
• Oncology
• Ophthalmology
• Cardiovascular Disorders
• Central Nervous System
• Pulmonary Disorders
• Orthopedics
• Other Applications
Based on Drug Type, the global market is segmented into the following sub-markets with annual revenue for 2015-2026 included in each section.
• Branded Prescription Drugs
• Generic Prescription Drugs
• OTC Drugs
Geographically, the following regions together with the listed national/local markets are fully investigated:
• APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka)
• Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Belgium, Denmark, Austria, Norway, Sweden, The Netherlands, Poland, Czech Republic, Slovakia, Hungary, and Romania)
• North America (U.S., Canada, and Mexico)
• South America (Brazil, Chile, Argentina, Rest of South America)
• RoW (Saudi Arabia, UAE, South Africa)
For each aforementioned region and country, detailed analysis and data for annual revenue are available for 2015-2026. The breakdown of all regional markets by country and split of key national markets by Synthesis, Manufacturing Process, and Therapeutic Application over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Specifically, potential risks associated with investing in global API market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.
Key Players (this may not be a complete list and extra companies can be added upon request):
AbbVie Inc.
Astrazeneca
Aurobindo Pharma Ltd.
Bayer Healthcare
Bioniche Animal Health
Boehringer Ingelheim
Bristol-Myers Squibb
Ceva Animal Health, Inc.
Elanco Animal Health
Eli Lilly and Company
F. Hoffmann-La Roche
Glaxosmithkline PLC
Heska Co.
Lonza Group
Merck & Co., Inc.
Novartis International AG
Pfizer, Inc.
Ranbaxy Laboratories
Sanofi
Sun Pharmaceutical Industries Ltd.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
1 Introduction 11
1.1 Industry Definition and Research Scope 11
1.1.1 Industry Definition 11
1.1.2 Research Scope 12
1.2 Research Methodology 15
1.2.1 Overview of Market Research Methodology 15
1.2.2 Market Assumption 16
1.2.3 Secondary Data 16
1.2.4 Primary Data 16
1.2.5 Data Filtration and Model Design 18
1.2.6 Market Size/Share Estimation 19
1.2.7 Research Limitations 20
1.3 Executive Summary 21
2 Market Overview and Dynamics 23
2.1 Market Size and Forecast 23
2.2 Major Growth Drivers 24
2.3 Market Restraints and Challenges 28
2.4 Emerging Opportunities and Market Trends 31
2.5 Porter’s Fiver Forces Analysis 35
3 Segmentation of Global Market by Synthesis 39
3.1 Market Overview by Synthesis 39
3.2 Synthetic API 41
3.2.1 Branded Synthetic API 42
3.2.2 Generic Synthetic API 43
3.3 Biotech API 44
3.3.1 Biotech API by Drug Type 45
3.3.1.1 Monoclonal Antibodies 46
3.3.1.2 Recombinant Proteins 47
3.3.1.3 Vaccines 48
3.3.1.4 Other Biotech APIs 49
3.3.2 Biotech API by Customer Base 50
3.3.2.1 Innovative Biologic API 51
3.3.2.2 Generic Biosimilar API 52
3.3.3 Biotech API by Expression Technology 53
3.3.3.1 Mammalian Expression 54
3.3.3.2 Microbial Expression 55
3.3.3.3 Yeast Expression 56
3.3.3.4 Insect Expression 57
3.3.3.5 Other Expression Technologies 58
3.4 HPAPI 59
3.4.1 Branded HPAPI 60
3.4.2 Generic HPAPI 61
4 Segmentation of Global Market by Manufacturing Process 62
4.1 Market Overview by Manufacturing Process 62
4.2 Captive Manufacturing 64
4.2.1 Branded Captive API 65
4.2.2 Generic Captive API 66
4.3 Merchant Manufacturing 67
4.3.1 Merchant Manufacturing by Drug Type 68
4.3.1.1 Branded Merchant API 69
4.3.1.2 Generic Merchant API 70
4.3.2 Merchant Manufacturing by Drug Synthesis 71
4.3.2.1 Merchant Synthetic API 72
4.3.2.2 Merchant Biotech API 73
5 Segmentation of Global Market by Therapeutic Application 74
5.1 Market Overview by Therapeutic Application 74
5.2 Infectious Diseases 76
5.3 Oncology 77
5.4 Ophthalmology 78
5.5 Cardiovascular Disorders 79
5.6 Central Nervous System 80
5.7 Pulmonary Disorders 81
5.8 Orthopedics 82
5.9 Other Applications 83
6 Segmentation of Global Market by Drug Type 84
6.1 Market Overview by Drug Type 84
6.2 Branded Prescription Drugs 86
6.3 Generic Prescription Drugs 87
6.4 OTC Drugs 88
7 Segmentation of Global Market by Region 89
7.1 Geographic Market Overview 2019-2026 89
7.2 North America Market 2019-2026 by Country 95
7.2.1 Overview of North America Market 95
7.2.2 U.S. 98
7.2.3 Canada 102
7.2.4 Mexico 104
7.3 European Market 2019-2026 by Country 106
7.3.1 Overview of European Market 106
7.3.2 UK 109
7.3.3 France 111
7.3.4 Germany 113
7.3.5 Spain 115
7.3.6 Italy 117
7.3.7 Russia 119
7.3.8 Rest of European Market 121
7.4 Asia-Pacific Market 2019-2026 by Country 123
7.4.1 Overview of Asia-Pacific Market 123
7.4.2 China 126
7.4.3 Japan 128
7.4.4 India 131
7.4.5 Australia 133
7.4.6 South Korea 135
7.4.7 Rest of APAC Region 137
7.5 South America Market 2019-2026 by Country 139
7.5.1 Argentina 142
7.5.2 Brazil 144
7.5.3 Chile 146
7.5.4 Rest of South America Market 148
7.6 Rest of World Market 2019-2026 by Country 149
7.6.1 UAE 152
7.6.2 Saudi Arabia 154
7.6.3 South Africa 156
7.6.4 Other National Markets 158
8 Competitive Landscape 159
8.1 Overview of Key Vendors 159
8.2 New Product Launch, Partnership, Investment, and M&A 162
8.3 Company Profiles 163
AbbVie Inc. 163
Astrazeneca 165
Aurobindo Pharma Ltd. 166
Bayer Healthcare 167
Bioniche Animal Health 168
Boehringer Ingelheim 169
Bristol-Myers Squibb 170
Ceva Animal Health, Inc. 171
Elanco Animal Health 172
Eli Lilly and Company 173
F. Hoffmann-La Roche 174
Glaxosmithkline PLC 175
Heska Co. 176
Lonza Group 177
Merck & Co., Inc. 178
Novartis International AG 179
Pfizer, Inc. 180
Ranbaxy Laboratories 181
Sanofi 182
Sun Pharmaceutical Industries Ltd. 183
9 Investing in Global Market: Risk Assessment and Management 184
9.1 Risk Evaluation of Global Market 184
9.2 Critical Success Factors (CSFs) 187
Related Reports and Products 190
Table 1. Snapshot of Global Active Pharmaceutical Ingredients (API) Market, 2019-2026 22
Table 2. Main Product Trends and Market Opportunities in Global Active Pharmaceutical Ingredients (API) Market 31
Table 3. Global Active Pharmaceutical Ingredients (API) Market by Synthesis, 2015-2026, $ bn 39
Table 4. Global Active Pharmaceutical Ingredients (API) Market: Synthetic API by Drug Type, 2015-2026, $ bn 41
Table 5. Global Active Pharmaceutical Ingredients (API) Market: Biotech API by Drug Type, 2015-2026, $ bn 45
Table 6. Global Active Pharmaceutical Ingredients (API) Market: Biotech API by Customer Base, 2015-2026, $ bn 50
Table 7. Global Active Pharmaceutical Ingredients (API) Market: Biotech API by Expression Technology, 2015-2026, $ bn 53
Table 8. Global Active Pharmaceutical Ingredients (API) Market: HPAPI by Drug Type, 2015-2026, $ bn 59
Table 9. Global Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2015-2026, $ bn 62
Table 10. Global Active Pharmaceutical Ingredients (API) Market: Captive Manufacturing by Drug Type, 2015-2026, $ bn 64
Table 11. Global Active Pharmaceutical Ingredients (API) Market: Merchant Manufacturing by Drug Type, 2015-2026, $ bn 68
Table 12. Global Active Pharmaceutical Ingredients (API) Market: Merchant Manufacturing by Drug Synthesis, 2015-2026, $ bn 71
Table 13. Global Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2015-2026, $ bn 74
Table 14. Global Active Pharmaceutical Ingredients (API) Market by Drug Type, 2015-2026, $ bn 84
Table 15. Global Active Pharmaceutical Ingredients (API) Market by Region, 2015-2026, $ bn 90
Table 16. Total Health Expenditure per capita in PPP International U.S. Dollars by Country 92
Table 17. Leading National Active Pharmaceutical Ingredients (API) Market, 2019 and 2026, $ bn 94
Table 18. North America Active Pharmaceutical Ingredients (API) Market by Country, 2015-2026, $ bn 97
Table 19. U.S. Active Pharmaceutical Ingredients (API) Market by Synthesis, 2015-2026, $ bn 100
Table 20. U.S. Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2015-2026, $ bn 100
Table 21. U.S. Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2015-2026, $ bn 100
Table 22. Canada Active Pharmaceutical Ingredients (API) Market by Synthesis, 2015-2026, $ bn 103
Table 23. Canada Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2015-2026, $ bn 103
Table 24. Canada Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2015-2026, $ bn 103
Table 25. Mexico Active Pharmaceutical Ingredients (API) Market by Synthesis, 2015-2026, $ bn 105
Table 26. Mexico Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2015-2026, $ bn 105
Table 27. Mexico Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2015-2026, $ bn 105
Table 28. Europe Active Pharmaceutical Ingredients (API) Market by Country, 2015-2026, $ bn 108
Table 29. UK Active Pharmaceutical Ingredients (API) Market by Synthesis, 2015-2026, $ bn 110
Table 30. UK Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2015-2026, $ bn 110
Table 31. UK Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2015-2026, $ bn 110
Table 32. France Active Pharmaceutical Ingredients (API) Market by Synthesis, 2015-2026, $ bn 112
Table 33. France Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2015-2026, $ bn 112
Table 34. France Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2015-2026, $ bn 112
Table 35. Germany Active Pharmaceutical Ingredients (API) Market by Synthesis, 2015-2026, $ bn 114
Table 36. Germany Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2015-2026, $ bn 114
Table 37. Germany Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2015-2026, $ bn 114
Table 38. Spain Active Pharmaceutical Ingredients (API) Market by Synthesis, 2015-2026, $ bn 116
Table 39. Spain Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2015-2026, $ bn 116
Table 40. Spain Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2015-2026, $ bn 116
Table 41. Italy Active Pharmaceutical Ingredients (API) Market by Synthesis, 2015-2026, $ bn 118
Table 42. Italy Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2015-2026, $ bn 118
Table 43. Italy Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2015-2026, $ bn 118
Table 44. Russia Active Pharmaceutical Ingredients (API) Market by Synthesis, 2015-2026, $ bn 120
Table 45. Russia Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2015-2026, $ bn 120
Table 46. Russia Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2015-2026, $ bn 120
Table 47. Active Pharmaceutical Ingredients (API) Market in Rest of Europe by Country, 2015-2026, $ bn 122
Table 48. APAC Active Pharmaceutical Ingredients (API) Market by Country, 2015-2026, $ bn 125
Table 49. China Active Pharmaceutical Ingredients (API) Market by Synthesis, 2015-2026, $ bn 127
Table 50. China Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2015-2026, $ bn 127
Table 51. China Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2015-2026, $ bn 127
Table 52. Japan Active Pharmaceutical Ingredients (API) Market by Synthesis, 2015-2026, $ bn 130
Table 53. Japan Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2015-2026, $ bn 130
Table 54. Japan Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2015-2026, $ bn 130
Table 55. India Active Pharmaceutical Ingredients (API) Market by Synthesis, 2015-2026, $ bn 132
Table 56. India Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2015-2026, $ bn 132
Table 57. India Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2015-2026, $ bn 132
Table 58. Australia Active Pharmaceutical Ingredients (API) Market by Synthesis, 2015-2026, $ bn 134
Table 59. Australia Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2015-2026, $ bn 134
Table 60. Australia Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2015-2026, $ bn 134
Table 61. South Korea Active Pharmaceutical Ingredients (API) Market by Synthesis, 2015-2026, $ bn 136
Table 62. South Korea Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2015-2026, $ bn 136
Table 63. South Korea Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2015-2026, $ bn 136
Table 64. Active Pharmaceutical Ingredients (API) Market in Rest of APAC by Country, 2015-2026, $ bn 138
Table 65. South America Active Pharmaceutical Ingredients (API) Market by Country, 2015-2026, $ bn 141
Table 66. Argentina Active Pharmaceutical Ingredients (API) Market by Synthesis, 2015-2026, $ bn 143
Table 67. Argentina Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2015-2026, $ bn 143
Table 68. Argentina Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2015-2026, $ bn 143
Table 69. Brazil Active Pharmaceutical Ingredients (API) Market by Synthesis, 2015-2026, $ bn 145
Table 70. Brazil Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2015-2026, $ bn 145
Table 71. Brazil Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2015-2026, $ bn 145
Table 72. Chile Active Pharmaceutical Ingredients (API) Market by Synthesis, 2015-2026, $ bn 147
Table 73. Chile Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2015-2026, $ bn 147
Table 74. Chile Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2015-2026, $ bn 147
Table 75. RoW Active Pharmaceutical Ingredients (API) Market by Country, 2015-2026, $ bn 151
Table 76. UAE Active Pharmaceutical Ingredients (API) Market by Synthesis, 2015-2026, $ bn 153
Table 77. UAE Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2015-2026, $ bn 153
Table 78. UAE Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2015-2026, $ bn 153
Table 79. Saudi Arabia Active Pharmaceutical Ingredients (API) Market by Synthesis, 2015-2026, $ bn 155
Table 80. Saudi Arabia Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2015-2026, $ bn 155
Table 81. Saudi Arabia Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2015-2026, $ bn 155
Table 82. South Africa Active Pharmaceutical Ingredients (API) Market by Synthesis, 2015-2026, $ bn 157
Table 83. South Africa Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2015-2026, $ bn 157
Table 84. South Africa Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2015-2026, $ bn 157
Table 85. AbbVie Inc.: Company Snapshot 163
Table 86. AbbVie Inc.: Business Segmentation 163
Table 87. AbbVie Inc.: Product Portfolio 164
Table 88. AbbVie Inc.: Revenue, 2016-2018, $ bn 164
Table 89. AbbVie Inc.: Recent Developments 164
Table 90. Risk Evaluation for Investing in Global Market, 2019-2026 185
Table 91. Critical Success Factors and Key Takeaways 188
